- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kerala Ayurveda's Board has approved its financial results for the quarter and nine months ended 31st December 2025, reporting consolidated revenue of 32.96 Cr and a net loss of 4.60 Cr for the quarter. The company also approved a preferential issue of 6.30 lakh shares worth 20.66 Cr to convert a promoter loan. Additionally, it will acquire the remaining 26% stake in subsidiary Ayurvedagram for 9.99 Cr, issuing 3.05 lakh shares, making it a wholly-owned subsidiary. An Extra-Ordinary General Meeting is scheduled to obtain shareholder approval for these equity issues. The company also granted 12,868 employee stock options.